Keyword: Advent

News

Baxter Sells BioPharma to Private Equity

10.05.2023 -

Confirming media reports, Baxter International announced it has agreed to sell its BioPharma Solutions (BPS) business to a private equity consortium of Warburg Pincus and...

News

Private Equity Steps up for Baxter Biopharma

09.05.2023 -

A private equity consortium of Warburg Pincus and Advent International is said to be in advanced talks to acquire medical device maker Baxter International’s biopharma...

News

Lanxess-Advent Plastics JV Launched as Envalior

04.04.2023 -

Under the name Envalior, German specialty chemicals producer Lanxess and private equity investor Advent International launched their new 40:60 joint venture for high...

Markets & Companies

Chemicals M&A Review 2022 and Outlook 2023

17.03.2023 -

2021 was historic for chemical M&As, it was a record-breaking year in terms of total value of deals. Therefore, it was expected that 2022 would only build upon this...

News

All Signals Point to ”Go” for new Plastics Firm

16.02.2023 -

With merger clearance granted by India this week, nothing now stands in the way of plans by German chemical producer Lanxess and private equity investor Advent...

News

Advent-Lanxess Materials JV Takes Shape

11.10.2022 -

The planned 60:40 specialty materials joint venture of German chemical producer and private equity group Advent International, announced at the end of May, is gradually...

News

Sanofi Agrees to sell Generics to Advent

12.07.2018 - French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9...

News

Sanofi and Advent in Talks Over Generics

18.04.2018 - French drugmaker Sanofi has confirmed market speculation that it is talking to Advent International about a sale of its European generics division, which trades as Zentiva. The...